Imatinib-induced erythroderma mediated by an unusual non-dose-dependent mechanism

Eur J Dermatol. 2007 Nov-Dec;17(6):538-9. doi: 10.1684/ejd.2007.0273. Epub 2007 Oct 19.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / adverse effects*
  • Benzamides
  • Dermatitis, Exfoliative / chemically induced*
  • Dermatitis, Exfoliative / pathology
  • Dose-Response Relationship, Drug
  • Drug Eruptions / etiology*
  • Drug Eruptions / pathology
  • Humans
  • Imatinib Mesylate
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy
  • Male
  • Piperazines / administration & dosage
  • Piperazines / adverse effects*
  • Pyrimidines / administration & dosage
  • Pyrimidines / adverse effects*
  • Skin / pathology

Substances

  • Antineoplastic Agents
  • Benzamides
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate